Growth Metrics

Bioventus (BVS) Operating Income Growth (3y) (2023 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -3.76%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 8.39%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 1.70%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 25.88%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 7.13%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 34.83%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 75.54%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -2.70%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -24.91%
10 Bioventus 535.01 Mn 544.52 Mn 90.77 Mn 27.88%

Historic Data

Download Data 🔒
DateValue
Mar 28, 2026 27.88%
Dec 31, 2025 48.07%
Sep 27, 2025 27.83%
Jun 28, 2025 96.20%
Mar 29, 2025 30.59%
Dec 31, 2024 64.43%
Sep 28, 2024 76.34%
Jun 29, 2024 -76.34%
Mar 30, 2024 -39.27%
Dec 31, 2023 -41.79%
Sep 30, 2023 -29.61%
Jul 1, 2023 51.39%
Apr 1, 2023 -108.68%